Avient Toekomstige groei
Future criteriumcontroles 1/6
Avient zal naar verwachting groeien in winst en omzet met respectievelijk 16.4% en 3.7% per jaar. De winst per aandeel zal naar verwachting groeien met 16.1% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 10.4% zijn.
Belangrijke informatie
16.4%
Groei van de winst
16.11%
Groei van de winst per aandeel
| Chemicals winstgroei | 17.1% |
| Inkomstengroei | 3.7% |
| Toekomstig rendement op eigen vermogen | 10.40% |
| Dekking van analisten | Good |
| Laatst bijgewerkt | 08 May 2026 |
Recente toekomstige groei-updates
Recent updates
Analyse-update • Apr 22
AVNT: Future Crude Linked Cost Controls Will Support ReRating Potential
Analysts have maintained Avient’s fair value estimate at $48.57 while refining assumptions, including a slightly lower discount rate. This reflects recent price target increases from several firms, alongside a more cautious sector stance from others.Analyse-update • Apr 08
AVNT: Future Crude Linked Cost Management Will Drive ReRating Potential
Analysts have modestly adjusted their price target on Avient to $48.57, with updated assumptions reflecting a slightly lower discount rate and broadly unchanged expectations for revenue growth, profit margins, and future P/E. Recent Street research cites higher crude linked input costs and mixed sector views, alongside higher individual firm targets up to $52.Analyse-update • Mar 24
AVNT: Future Commodity Cost Management Will Drive ReRating Potential
Narrative Update The updated analyst price target for Avient edges lower by about $1, reflecting slightly higher discount rate assumptions and cautious views on raw material cost pressures. This comes even as several firms have recently lifted their individual targets following earnings and valuation roll-forwards.Analyse-update • Mar 08
AVNT: Future End Market Recovery And Higher P/E Are Expected To ReRate Shares
Narrative Update on Avient Our analyst price target for Avient edges up from $48.25 to $49.50 as analysts cite updated valuation work, including higher forward price targets and refined expectations for revenue growth, profit margins and future P/E multiples following recent sector and company specific research. Analyst Commentary Recent research on Avient shows a mix of optimism about the longer term setup and caution around near term input cost and industry headwinds.Analyse-update • Feb 21
AVNT: Demand Recovery In Key End Markets Will Drive Future Multiple
The analyst fair value estimate for Avient has moved from $41.75 to $48.25, reflecting higher Street price targets as analysts update their models and adjust assumptions around future revenue growth, profit margins, and P/E multiples. Analyst Commentary Street research on Avient over the past few months has centered on revised valuation frameworks, longer dated earnings assumptions, and how quickly demand in key end markets might stabilize.Analyse-artikel • Feb 19
There May Be Reason For Hope In Avient's (NYSE:AVNT) Disappointing Earnings
Avient Corporation's ( NYSE:AVNT ) recent soft profit numbers didn't appear to worry shareholders, as the stock price...Seeking Alpha • Feb 18
Avient: Becoming A Better Business
Summary Avient has demonstrated solid operating momentum and resilient execution, with shares enjoying a notable re-rating amid challenging industry conditions. Avient's 2026 outlook targets adjusted EBITDA of $555–$585 million and an adjusted EPS midpoint of $3.05, driven by productivity and innovation, not macro recovery. Leverage has improved to 2.6x, and valuation has expanded to 14x adjusted earnings, reflecting investor confidence in management's strategy and product pipeline. Despite a 30% share price gain in six months, Avient remains reasonably valued, but further upside may prompt position trimming on strength. Read the full article on Seeking Alpha
Nieuwe analyse • Feb 16
Defense And Healthcare Materials Will Drive A Stronger Long Term Outlook
Catalysts About Avient Avient supplies specialized materials and color and additive solutions for end markets such as health care, defense, telecommunications, packaging and transportation. What are the underlying business or industry changes driving this perspective?Analyse-update • Feb 06
AVNT: Fair View Suggests Demand Recovery And Margins Will Drive Future Multiple
Narrative Update on Avient The analyst price target for Avient has been updated to US$41.75, a US$4.75 increase from the prior US$37 level. This change reflects a combination of higher targets from some firms and lower targets from others, as well as modest adjustments to assumptions for discount rate, revenue growth, profit margin and future P/E.Analyse-update • Jan 23
AVNT: Fair View Suggests Execution Will Shape Future Multiple Potential
Narrative Update on Avient The analyst price target for Avient has been adjusted slightly higher from $41.00 to $41.75, reflecting analysts’ updated views on earnings quality and valuation following recent target changes across the Street. Analyst Commentary Recent research updates on Avient present a mixed picture, with some analysts lifting targets and others trimming them, reflecting different views on how the company might execute in a challenging industry setup.Analyse-update • Jan 08
AVNT: Reset Price View Will Support Future Multiple Expansion
Narrative Update Overview Analysts have trimmed their price target on Avient to US$36 from US$42, reflecting updated views on the shares while maintaining broadly consistent assumptions for fair value, discount rate, revenue growth, profit margin, and future P/E. Analyst Commentary Recent commentary on Avient centers on the reset in the price target to US$36.Analyse-update • Dec 23
AVNT: Dividend And Buyback Execution Will Support Future Multiple Expansion
Avient's analyst price target has been reduced by $6 to $36, as analysts factor in more conservative expectations for the shares while maintaining a positive long term outlook. Analyst Commentary Analysts are recalibrating their expectations for Avient, balancing a still constructive long term view on execution and earnings power with a more tempered near term valuation framework.Analyse-update • Dec 09
AVNT: New Leadership Will Drive 4% Organic Expansion As Cyclical Headwinds Ease
Avient's updated analyst price target has edged lower, reflecting a recalibration toward the mid 30 dollar to high 40 dollar range as analysts balance near term macro and cyclical pressures against improving margin prospects and the potential for faster organic growth under the new strategic focus. Analyst Commentary Recent Street research reflects a balanced mix of optimism around Avient's strategic pivot and caution on near term earnings power, resulting in a wide but grounded valuation range.Analyse-update • Nov 24
AVNT: Renewed Leadership Will Drive Recovery With 4% Organic Expansion Ahead
Analysts have trimmed their price target for Avient by $1.13 to $41.00. This reflects cautious sentiment following reduced profit margin forecasts and recent reassessments of growth potential.Analyse-update • Nov 07
AVNT: Renewed Leadership Will Drive Recovery In High-Growth End Markets
Analysts have modestly reduced their fair value estimate for Avient from $43.25 to $42.13. They cite a more conservative revenue growth outlook, even though profit margins and long-term growth opportunities continue to be supported by recent positive coverage and management strategy shifts.Analyse-artikel • Nov 05
Avient (NYSE:AVNT) Will Pay A Larger Dividend Than Last Year At $0.275
The board of Avient Corporation ( NYSE:AVNT ) has announced that the dividend on 7th of January will be increased to...Analyse-artikel • Oct 12
Avient (NYSE:AVNT) Is Increasing Its Dividend To $0.275
Avient Corporation's ( NYSE:AVNT ) dividend will be increasing from last year's payment of the same period to $0.275 on...Analyse-update • Sep 18
High-Performance Healthcare Materials And Sustainable Polymers Will Create Value
Analysts have raised Avient’s price target to $43.25, citing increased confidence in the new CEO’s strategic focus on high-growth markets, anticipated organic growth, and recovery potential in cyclical end markets. Analyst Commentary Increased optimism due to the new CEO's strategic focus on high-growth platforms and markets.Analyse-artikel • Sep 13
Avient Corporation's (NYSE:AVNT) Earnings Haven't Escaped The Attention Of Investors
With a price-to-earnings (or "P/E") ratio of 27.9x Avient Corporation ( NYSE:AVNT ) may be sending bearish signals at...Analyse-artikel • Jul 14
Are Investors Undervaluing Avient Corporation (NYSE:AVNT) By 30%?
Key Insights Avient's estimated fair value is US$48.56 based on 2 Stage Free Cash Flow to Equity Current share price of...Analyse-artikel • May 23
Is Avient Corporation (NYSE:AVNT) Potentially Undervalued?
Avient Corporation ( NYSE:AVNT ), might not be a large cap stock, but it saw a significant share price rise of 25% in...Analyse-artikel • May 08
Is Avient (NYSE:AVNT) A Risky Investment?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Analyse-artikel • Apr 07
Is There An Opportunity With Avient Corporation's (NYSE:AVNT) 49% Undervaluation?
Key Insights Avient's estimated fair value is US$60.06 based on 2 Stage Free Cash Flow to Equity Avient's US$30.43...Analyse-artikel • Mar 23
Some Confidence Is Lacking In Avient Corporation's (NYSE:AVNT) P/E
With a price-to-earnings (or "P/E") ratio of 20.7x Avient Corporation ( NYSE:AVNT ) may be sending bearish signals at...Seeking Alpha • Mar 22
Avient: Specialty Play Slowly Becomes More Special
Summary Avient Corporation has returned to growth in 2024, with promising projections for 2025, despite past disappointments and mixed earnings metrics. The company, specializing in material solutions, aims for organic growth and 20% EBITDA margins, but hasn't yet achieved these targets. Trading at $38 per share, Avient's valuation appears reasonable, but earnings will again be highly adjusted due to significant charges. While the 2025 outlook is strong, I remain cautious and seek a better entry point before initiating a long position. Read the full article on Seeking AlphaAnalyse-artikel • Feb 19
At US$44.21, Is Avient Corporation (NYSE:AVNT) Worth Looking At Closely?
While Avient Corporation ( NYSE:AVNT ) might not have the largest market cap around , it saw a decent share price...Analyse-artikel • Jan 20
Does Avient (NYSE:AVNT) Have A Healthy Balance Sheet?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...Analyse-artikel • Jan 03
An Intrinsic Calculation For Avient Corporation (NYSE:AVNT) Suggests It's 31% Undervalued
Key Insights Avient's estimated fair value is US$57.96 based on 2 Stage Free Cash Flow to Equity Avient is estimated to...Analyse-artikel • Dec 18
Earnings Tell The Story For Avient Corporation (NYSE:AVNT)
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 18x, you may...Analyse-artikel • Nov 18
Is It Time To Consider Buying Avient Corporation (NYSE:AVNT)?
Avient Corporation ( NYSE:AVNT ), is not the largest company out there, but it saw a decent share price growth of 13...Seeking Alpha • Nov 13
Avient: Specialization Strategy Is Growing Margins And Driving The Bottom-Line Growth
Summary AVNT's gross profit margins have improved by over 70% in the last decade, indicating a shift to higher-margin specialty services. The company is focused on deleveraging, with share repurchases on hold until net debt-to-EBITDA reaches 2.5x, despite recent acquisitions. AVNT announced its 14th consecutive annual dividend increase, with a 5% hike, and aims to return to a safer payout ratio by 2026. With projected double-digit EPS growth and a potential P/E Ratio of 20.6x, AVNT is rated as a BUY with an estimated share price of $61.80 by the 2025 year-end. Read the full article on Seeking AlphaAnalyse-artikel • Nov 02
Avient's (NYSE:AVNT) Dividend Will Be Increased To $0.27
Avient Corporation's ( NYSE:AVNT ) dividend will be increasing from last year's payment of the same period to $0.27 on...Analyse-artikel • Sep 26
Avient (NYSE:AVNT) Seems To Use Debt Quite Sensibly
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
Nieuwe analyse • Sep 02
Navigating Challenges, The Company Leverages Healthcare Innovations And Tactical Partnerships For Growth
Avient's strategy focuses on market share gain in varied sectors, especially healthcare, promising revenue growth with innovations like drug delivery devices.Analyse-artikel • Aug 03
A Look At The Intrinsic Value Of Avient Corporation (NYSE:AVNT)
Key Insights Avient's estimated fair value is US$37.54 based on 2 Stage Free Cash Flow to Equity With US$42.83 share...Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 12/31/2028 | 3,641 | 264 | 258 | 428 | 4 |
| 12/31/2027 | 3,494 | 232 | 236 | 377 | 7 |
| 12/31/2026 | 3,372 | 232 | 194 | 324 | 8 |
| 3/31/2026 | 3,281 | 158 | 205 | 318 | N/A |
| 12/31/2025 | 3,260 | 82 | 195 | 302 | N/A |
| 9/30/2025 | 3,246 | 113 | 151 | 256 | N/A |
| 6/30/2025 | 3,255 | 119 | 150 | 255 | N/A |
| 3/31/2025 | 3,238 | 100 | 139 | 249 | N/A |
| 12/31/2024 | 3,240 | 170 | 135 | 257 | N/A |
| 9/30/2024 | 3,213 | 149 | 164 | 289 | N/A |
| 6/30/2024 | 3,151 | 116 | 160 | 289 | N/A |
| 3/31/2024 | 3,126 | 104 | 58 | 181 | N/A |
| 12/31/2023 | 3,143 | 76 | 82 | 202 | N/A |
| 9/30/2023 | 3,214 | 31 | 96 | 222 | N/A |
| 6/30/2023 | 3,284 | -1 | 150 | 267 | N/A |
| 3/31/2023 | 3,350 | 39 | 245 | 357 | N/A |
| 12/31/2022 | 3,397 | 83 | 293 | 398 | N/A |
| 9/30/2022 | 3,414 | 108 | 255 | 348 | N/A |
| 6/30/2022 | 3,408 | 169 | 180 | 272 | N/A |
| 3/31/2022 | 3,045 | 137 | 152 | 249 | N/A |
| 12/31/2021 | 3,316 | 152 | 133 | 234 | N/A |
| 9/30/2021 | 3,506 | 218 | 175 | 263 | N/A |
| 6/30/2021 | 3,612 | 186 | 129 | 214 | N/A |
| 3/31/2021 | 3,693 | 178 | 169 | 238 | N/A |
| 12/31/2020 | 2,215 | 71 | 158 | 222 | N/A |
| 9/30/2020 | 2,904 | 64 | 99 | 171 | N/A |
| 6/30/2020 | 2,685 | 86 | 201 | 277 | N/A |
| 3/31/2020 | 2,824 | 86 | 230 | 313 | N/A |
| 12/31/2019 | 2,863 | 76 | N/A | 301 | N/A |
| 9/30/2019 | 2,881 | 68 | N/A | 281 | N/A |
| 6/30/2019 | 2,905 | 77 | N/A | 244 | N/A |
| 3/31/2019 | 2,730 | 62 | N/A | 202 | N/A |
| 12/31/2018 | 2,881 | 88 | N/A | 254 | N/A |
| 9/30/2018 | 3,005 | 124 | N/A | 262 | N/A |
| 6/30/2018 | 3,094 | 132 | N/A | 268 | N/A |
| 3/31/2018 | 3,335 | 173 | N/A | 253 | N/A |
| 12/31/2017 | 2,590 | 111 | N/A | 202 | N/A |
| 9/30/2017 | 3,124 | 173 | N/A | 206 | N/A |
| 6/30/2017 | 3,052 | 176 | N/A | 217 | N/A |
| 3/31/2017 | 2,996 | 176 | N/A | 227 | N/A |
| 12/31/2016 | 2,939 | 166 | N/A | 228 | N/A |
| 9/30/2016 | 3,020 | 134 | N/A | 231 | N/A |
| 6/30/2016 | 3,115 | 136 | N/A | 222 | N/A |
| 3/31/2016 | 3,243 | 153 | N/A | 262 | N/A |
| 12/31/2015 | 2,929 | 148 | N/A | 240 | N/A |
| 9/30/2015 | 3,471 | 127 | N/A | 205 | N/A |
| 6/30/2015 | 3,588 | 115 | N/A | 225 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachte winstgroei AVNT ( 16.4% per jaar) ligt boven de spaarquote ( 3.5% ).
Winst versus markt: De winst van AVNT ( 16.4% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 16.7% per jaar).
Hoge groeiwinsten: De winst van AVNT zal naar verwachting groeien, maar niet aanzienlijk.
Omzet versus markt: De omzet van AVNT ( 3.7% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 11.6% per jaar).
Hoge groei-inkomsten: De omzet van AVNT ( 3.7% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Het rendement op eigen vermogen AVNT zal naar verwachting over 3 jaar laag zijn ( 10.4 %).
Ontdek groeibedrijven
Bedrijfsanalyse en status van financiële gegevens
| Gegevens | Laatst bijgewerkt (UTC-tijd) |
|---|---|
| Bedrijfsanalyse | 2026/05/11 17:55 |
| Aandelenkoers aan het einde van de dag | 2026/05/11 00:00 |
| Inkomsten | 2026/03/31 |
| Jaarlijkse inkomsten | 2025/12/31 |
Gegevensbronnen
De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.
| Pakket | Gegevens | Tijdframe | Voorbeeld Amerikaanse bron * |
|---|---|---|---|
| Financiële gegevens bedrijf | 10 jaar |
| |
| Consensus schattingen analisten | +3 jaar |
|
|
| Marktprijzen | 30 jaar |
| |
| Eigendom | 10 jaar |
| |
| Beheer | 10 jaar |
| |
| Belangrijkste ontwikkelingen | 10 jaar |
|
* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.
Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.
Analysemodel en Snowflake
Details van het analysemodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen over hoe je onze rapporten kunt gebruiken en tutorials op YouTube.
Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.
Industrie en sector
Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.
Bronnen van analisten
Avient Corporation wordt gevolgd door 18 analisten. 8 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.
| Analist | Instelling |
|---|---|
| Ghansham Panjabi | Baird |
| Prashant Juvekar | Citigroup Inc |
| David Begleiter | Deutsche Bank |